Results 1 to 10 of about 9,896 (218)

Comparison of two immunotoxins against DLL3 receptor; as an inhibitor for small cell lung cancer [PDF]

open access: yesFrontiers in Molecular Biosciences
Despite the efforts of researchers to develop new treatments for small cell lung cancer (SCLC), achieving effective treatment has not yet happened. Targeted therapy utilizing delta-like ligand 3 (DLL3), which is highly expressed in SCLC patients, holds ...
Mohammad Hossein Ataee   +4 more
doaj   +2 more sources

Anti-tumoral potential of a human granulysin-based, CEA-targeted cytolytic immunotoxin

open access: yesOncoImmunology, 2019
Granulysin is a protein present in the granules of human cytotoxic T lymphocytes (CTL) and natural killer (NK) cells, with cytolytic activity against microbes and tumors.
Patricia Guerrero-Ochoa   +2 more
exaly   +2 more sources

Integrated bioprocessing and genetic strategies to enhance soluble expression of anti-HER2 immunotoxin in E. Coli [PDF]

open access: yesAMB Express
Immunotoxins are widely applied for cancer therapy. However, bacterial expression of immunotoxins usually leads to the formation of insoluble and non-functional recombinant proteins. This study was aimed to improve soluble expression of a novel anti-HER2
Sheida Mani   +3 more
doaj   +2 more sources

Immunotoxin Treatment of Cancer* [PDF]

open access: yesAnnual Review of Medicine, 2007
Immunotoxins are proteins used to treat cancer that are composed of an antibody fragment linked to a toxin. The immunotoxin binds to a surface antigen on a cancer cell, enters the cell by endocytosis, and kills it. The most potent immunotoxins are made from bacterial and plant toxins.
Ira Pastan   +2 more
exaly   +3 more sources

CD30 as a Target Molecule in the Diagnosis and Therapy of Lymphomas. [PDF]

open access: yesAm J Hematol
ABSTRACT The tumor necrosis factor (TNF)‐receptor superfamily 8 receptor CD30 molecule is expressed in all tumor cells of Hodgkin lymphoma and anaplastic large cell lymphoma but is only weakly expressed in a small subset of large lymphoid cells in normal peripheral lymphoid tissues.
Stein H, Falini B.
europepmc   +2 more sources

Immunotoxins: The Role of the Toxin [PDF]

open access: yesToxins, 2013
Immunotoxins are antibody-toxin bifunctional molecules that rely on intracellular toxin action to kill target cells. Target specificity is determined via the binding attributes of the chosen antibody. Mostly, but not exclusively, immunotoxins are purpose-
David FitzGerald, Antonella Antignani
doaj   +3 more sources

Unlocking the potential of engineered microbes in immunotoxin-based cancer therapy [PDF]

open access: yesFrontiers in Microbiology
Immunotoxins (ITs), as targeted cancer therapies, confront limitations including off-target effects, immunogenicity, and inadequate tumor penetration, hindering clinical translation.
Quan Wang   +10 more
doaj   +2 more sources

Production and Verification of Anti-Tumor Activity of Monoclonal Anti-EGFR-Recombinant PE38 Immunotoxin in A431 Tumor Cells [PDF]

open access: yesImmunoAnalysis, 2021
Background: Tumor growth and progression depend largely on the activity of cell membrane receptors like epidermal growth factor receptor (EGFR). This receptor plays a significant role in the growth and survival of many solid tumors.
Khalil Hajiasgharzadeh   +2 more
doaj   +1 more source

In vivo solid tumor targeting with recombinant VEGF-diphtheria immunotoxin [PDF]

open access: yesIranian Journal of Basic Medical Sciences, 2022
Objective(s): A variety of signaling molecules have been identified that play a role in angiogenesis, of prime importance, vascular endothelial growth factor (VEGF) and its resceptor (VEGFR), which is highly expressed in most human solid tumors ...
Mohammad Hosseininejad-Chafi   +9 more
doaj   +1 more source

An immunotoxin targeting Ebola virus glycoprotein inhibits Ebola virus production from infected cells.

open access: yesPLoS ONE, 2021
Ebola virus (EBOV), a member of the mononegaviral family Filoviridae, causes severe disease associated with high lethality in humans. Despite enormous progress in development of EBOV medical countermeasures, no anti-EBOV treatment has been approved.
Yingyun Cai   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy